Drug Distributor Stymied On FDA Topics In Wash. Trial Cross

By Cara Salvatore (February 2, 2022, 10:50 PM EST) -- Opioid distributor McKesson was blocked Wednesday from delving into information about U.S. Food and Drug Administration drug approval processes that McKesson's counsel called "a meaningful element of our defense" during cross-examination of a Harvard health economist at trial in Seattle....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!